The Southeast Asian nation, a densely packed regional financial hub with a population of about 5.7 million, is seeking to attract more businesses and investors through the use of advanced technologies. The city-state plans to roll out artificial intelligence and cloud-based solutions to every business sector by 2020, Iswaran said Mar 4.
“We must continue to emphasise science and technology throughout our society,” Prime Minister Lee Hsien Loong, who chairs the panel, said at a briefing Wednesday. “We can’t afford to have people fearful and distrustful of science, and held captive by totally groundless anti-scientific beliefs.”
The government will invest $80 million to develop cell-therapy manufacturing to build on its success in the biopharmaceutical sector, which contributed 4% to gross domestic product in 2018 and employs more than 7,700 highly skilled workers. Cell therapy involves injecting living cells into a patient to derive a therapeutic effect such as restoring tissue functions or fighting cancer.
Singapore will also set aside as much as $144 million for food-related innovations to help in sustainable urban production. These will involve tropical aquaculture, urban agriculture, and advanced biotech-based protein production. The nation aims to produce 30% of its nutritional needs locally by 2030.
The panel noted that global demand for proteins is expected to increase significantly in the coming decades as the world population increases and income levels rise.
To capture the economic opportunities presented by this demand, the government will focus its research on plant and microbial-based proteins, as well as cell-based cultured meat. It will target investments to build on Singapore’s existing research capabilities in bio-engineering, nutrition, bio-processing and agri-food science to grow this new industry.
The figures announced Wednesday fall under a $19 billion budget for research, innovation and enterprise for a five-year period through 2020.
